Skip to main content
Top
Published in: Journal of Neurology 3/2011

01-03-2011 | Original Communication

Is there a delayed gastric emptying of patients with early-stage, untreated Parkinson’s disease? An analysis using the 13C-acetate breath test

Authors: Yuji Tanaka, Tomohiro Kato, Hiroshi Nishida, Megumi Yamada, Akihiro Koumura, Takeo Sakurai, Yuichi Hayashi, Akio Kimura, Isao Hozumi, Hiroshi Araki, Masahiko Murase, Masahito Nagaki, Hisataka Moriwaki, Takashi Inuzuka

Published in: Journal of Neurology | Issue 3/2011

Login to get access

Abstract

During the pre-symptomatic stage of Parkinson’s disease (PD), the idiopathic PD related abnormal synuclein immunostaining is confined to the medulla oblongata and olfactory bulb, according to Braak. In the study of the enteric nervous system of PD, it has reported that Lewy bodies were found in the Auerbach’s and Meissner’s plexuses. These lesions may cause dysfunction of the gastrointestinal tract (GI) as pre-clinical symptoms of PD. However, because l-dopa therapy itself may worsen the symptoms of the digestive tract function, it is needed to evaluate the gastrointestinal tract function in patients with early-stage, untreated (de novo) PD. In the present study, using the 13C-acetate breath test (13C-ABT), we investigated gastric emptying in 20 untreated, early-stage PD patients and 40 treated, advanced-stage PD patients, and 20 healthy volunteers. Gastric emptying was examined by the 13C-ABT [the half emptying time (HET), the peak time of the 13C% dose-excess curve (T max)]. The T max and HET of gastric emptying as assessed using the 13C-ABT was significantly delayed in untreated, early-stage PD patients as compared to the controls (P < 0.001). The T max and HET of gastric emptying were not significantly delayed in untreated, early-stage PD patients as compared to treated, advanced-stage PD patients. The results demonstrated that delay in gastric emptying did not differ between untreated, early-stage and treated, advanced-stage PD patients. Gastric emptying of untreated, early-stage PD is already delayed. Delayed gastric emptying may be one of markers of the pre-clinical stage of PD.
Literature
1.
go back to reference Djaldetti R, Baron J, Ziv I, Melamed E (1996) Gastric emptying in Parkinson’s disease: patients with and without response fluctuation. Neurology 46:1051–1054PubMed Djaldetti R, Baron J, Ziv I, Melamed E (1996) Gastric emptying in Parkinson’s disease: patients with and without response fluctuation. Neurology 46:1051–1054PubMed
2.
go back to reference Hardoff R, Sula M, Tamir A, Soil A, Front A, Badarna S, Honigman S, Giladi N (2001) Gastric emptying time and gastric motility in patients with Parkinson’s disease. Mov Disord 16:1041–1047PubMedCrossRef Hardoff R, Sula M, Tamir A, Soil A, Front A, Badarna S, Honigman S, Giladi N (2001) Gastric emptying time and gastric motility in patients with Parkinson’s disease. Mov Disord 16:1041–1047PubMedCrossRef
3.
go back to reference Soykan I, Sarosiek I, Shifflett J, Wooten GF, McCallum RW (1997) Effects of chronic oral domperidone therapy on gastrointestinal symptoms and gastric emptying in patients with Parkinson’s disease. Mov Disord 12:952–957PubMedCrossRef Soykan I, Sarosiek I, Shifflett J, Wooten GF, McCallum RW (1997) Effects of chronic oral domperidone therapy on gastrointestinal symptoms and gastric emptying in patients with Parkinson’s disease. Mov Disord 12:952–957PubMedCrossRef
4.
go back to reference Djaldetti R, Koren M, Ziv I, Achiron A, Melamed E (1995) Effect of cisapride on response fluctuations in Parkinson’s disease. Mov Disord 10:81–84PubMedCrossRef Djaldetti R, Koren M, Ziv I, Achiron A, Melamed E (1995) Effect of cisapride on response fluctuations in Parkinson’s disease. Mov Disord 10:81–84PubMedCrossRef
5.
go back to reference Tanaka Y, Kato T, Nishida H, Araki H, Murase M, Nagaki M, Moriwaki H, Inuzuka T (2009) Is there a difference in gastric emptying between Parkinson’s disease patients under long-term l-dopa therapy with and without motor fluctuations? An analysis using the 13C-acetate breath test. J Neurol 256:1972–1976CrossRef Tanaka Y, Kato T, Nishida H, Araki H, Murase M, Nagaki M, Moriwaki H, Inuzuka T (2009) Is there a difference in gastric emptying between Parkinson’s disease patients under long-term l-dopa therapy with and without motor fluctuations? An analysis using the 13C-acetate breath test. J Neurol 256:1972–1976CrossRef
6.
go back to reference Braak H, Del Tredici K, Bratzke H, Hamm-Clement J, Sandmann-Keil D, Rüb U (2002) Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson’s disease (preclinical and clinical stages). J Neurol 249(Suppl 3):III/1–III/5 Braak H, Del Tredici K, Bratzke H, Hamm-Clement J, Sandmann-Keil D, Rüb U (2002) Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson’s disease (preclinical and clinical stages). J Neurol 249(Suppl 3):III/1–III/5
7.
8.
go back to reference Bramble MG, Cunliffe J, Dellipiani AW (1978) Evidence for a change in neurotransmitter affecting oesophageal motility in Parkinson’s disease. J Neurol Neurosurg Psychiatry 41:709–712PubMedCrossRef Bramble MG, Cunliffe J, Dellipiani AW (1978) Evidence for a change in neurotransmitter affecting oesophageal motility in Parkinson’s disease. J Neurol Neurosurg Psychiatry 41:709–712PubMedCrossRef
9.
go back to reference Kurlan R, Nutt JG, Woodward WR, Rothfield K, Lichter D, Miller C, Carter JH, Shoulson I (1988) Duodenal and gastric delivery of levodopa in parkinsonism. Ann Neurol 23:589–595PubMedCrossRef Kurlan R, Nutt JG, Woodward WR, Rothfield K, Lichter D, Miller C, Carter JH, Shoulson I (1988) Duodenal and gastric delivery of levodopa in parkinsonism. Ann Neurol 23:589–595PubMedCrossRef
10.
go back to reference Ghoos YF, Maes BD, Geypens BJ, Mys G, Hiele MI, Rutgeerts PJ, Vantrappen G (1993) Measurement of gastric emptying rate of solids by means of a carbon-labeled octanoic acid breath test. Gastroenterology 104:1640–1647PubMed Ghoos YF, Maes BD, Geypens BJ, Mys G, Hiele MI, Rutgeerts PJ, Vantrappen G (1993) Measurement of gastric emptying rate of solids by means of a carbon-labeled octanoic acid breath test. Gastroenterology 104:1640–1647PubMed
11.
go back to reference Braden B, Adams S, Duan LP, Orth KH, Maul FD, Lembcke B, Hör G, Caspary WF (1995) The 13C-acetate breath test accurately reflects gastric emptying of liquids in both liquid and semisolid test meals. Gastroenterology 108:1048–1055PubMedCrossRef Braden B, Adams S, Duan LP, Orth KH, Maul FD, Lembcke B, Hör G, Caspary WF (1995) The 13C-acetate breath test accurately reflects gastric emptying of liquids in both liquid and semisolid test meals. Gastroenterology 108:1048–1055PubMedCrossRef
12.
go back to reference Goetze O, Nikodem AB, Wiezcorek J, Banasch M, Przuntek H, Mueller T, Schmidt WE, Woitalla D (2006) Predictors of gastric emptying in Parkinson’s disease. Neurogastroenterol Motil 18:369–375PubMedCrossRef Goetze O, Nikodem AB, Wiezcorek J, Banasch M, Przuntek H, Mueller T, Schmidt WE, Woitalla D (2006) Predictors of gastric emptying in Parkinson’s disease. Neurogastroenterol Motil 18:369–375PubMedCrossRef
13.
go back to reference Gibb WRG, Lees AJ (1988) The relevance of the Lewy body to pathogenesis of idiopathic Parkinson’s disease. J Neurol Neurosurg Psychiatry 51:745–752PubMedCrossRef Gibb WRG, Lees AJ (1988) The relevance of the Lewy body to pathogenesis of idiopathic Parkinson’s disease. J Neurol Neurosurg Psychiatry 51:745–752PubMedCrossRef
14.
go back to reference Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinicopathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181–184PubMedCrossRef Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinicopathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181–184PubMedCrossRef
15.
go back to reference Fahn S, Elton RL, Members of the UPDRS Development Committee (1987) Unified Parkinson’s disease rating scale. In: Fahn S, Marsden CD, Goldstein M, Calne DB (eds) Recent developments in Parkinson’s disease, vol II. Macmillan Healthcare Information, Florham Park, pp 153–163, 293–304 Fahn S, Elton RL, Members of the UPDRS Development Committee (1987) Unified Parkinson’s disease rating scale. In: Fahn S, Marsden CD, Goldstein M, Calne DB (eds) Recent developments in Parkinson’s disease, vol II. Macmillan Healthcare Information, Florham Park, pp 153–163, 293–304
16.
go back to reference Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression and mortality. Neurology 17:427–442PubMed Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression and mortality. Neurology 17:427–442PubMed
17.
go back to reference Yoshihara M, Sumii K, Haruma K, Kiyohira K, Hattori N, Kitadai Y, Komoto K, Tanaka S, Kajiyama G (1998) Correlation of ratio of serum pepsinogen I and II with prevalence of gastric cancer and adenoma in Japanese subjects. Am J Gastroenterol 93:1090–1096PubMedCrossRef Yoshihara M, Sumii K, Haruma K, Kiyohira K, Hattori N, Kitadai Y, Komoto K, Tanaka S, Kajiyama G (1998) Correlation of ratio of serum pepsinogen I and II with prevalence of gastric cancer and adenoma in Japanese subjects. Am J Gastroenterol 93:1090–1096PubMedCrossRef
18.
go back to reference Medow MS, Stewart JM, Sanyal S, Mumtaz A, Sica D, Frishman WH (2008) Pathophysiology, diagnosis, and treatment of orthostatic hypotension and vasovagal syncope. Cardiol Rev 16:4–20PubMedCrossRef Medow MS, Stewart JM, Sanyal S, Mumtaz A, Sica D, Frishman WH (2008) Pathophysiology, diagnosis, and treatment of orthostatic hypotension and vasovagal syncope. Cardiol Rev 16:4–20PubMedCrossRef
19.
go back to reference Kuroiwa Y, Wada T, Tohgi H (1987) Measurement of blood pressure and heart-rate variation while resting supine and standing for the evaluation of autonomic dysfunction. J Neurol 235:65–68PubMedCrossRef Kuroiwa Y, Wada T, Tohgi H (1987) Measurement of blood pressure and heart-rate variation while resting supine and standing for the evaluation of autonomic dysfunction. J Neurol 235:65–68PubMedCrossRef
20.
go back to reference Orimo S, Ozawa E, Nakade S, Sugimoto T, Mizusawa H (1999) (123)I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson’s disease. J Neurol Neurosurg Psychiatry 67:189–194PubMedCrossRef Orimo S, Ozawa E, Nakade S, Sugimoto T, Mizusawa H (1999) (123)I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson’s disease. J Neurol Neurosurg Psychiatry 67:189–194PubMedCrossRef
21.
go back to reference Gatti C, di Abriola FF, Dall’Oglio L, Villa M, Franchini F, Amarri S (2000) Is the 13C-acetate breath test a valid procedure to analyse gastric emptying in children? J Pediatr Surg 35:62–65PubMedCrossRef Gatti C, di Abriola FF, Dall’Oglio L, Villa M, Franchini F, Amarri S (2000) Is the 13C-acetate breath test a valid procedure to analyse gastric emptying in children? J Pediatr Surg 35:62–65PubMedCrossRef
22.
go back to reference Gonza´lez A, Mugueta C, Parra D, Labayen I, Martinez A, Varo N, Monreal I, Gil MJ (2000) Characterisation with stable isotopes of the presence of a lag phase in the gastric emptying of liquids. Eur J Nutr 39:224–228CrossRef Gonza´lez A, Mugueta C, Parra D, Labayen I, Martinez A, Varo N, Monreal I, Gil MJ (2000) Characterisation with stable isotopes of the presence of a lag phase in the gastric emptying of liquids. Eur J Nutr 39:224–228CrossRef
23.
go back to reference Wakabayashi K, Takahashi H, Takeda S, Ohama E, Ikuta F (1988) Parkinson’s disease: the presence of Lewy bodies in Auerbach’s and Meissner’s plexuses. Acta Neuropathol 76:217–221PubMedCrossRef Wakabayashi K, Takahashi H, Takeda S, Ohama E, Ikuta F (1988) Parkinson’s disease: the presence of Lewy bodies in Auerbach’s and Meissner’s plexuses. Acta Neuropathol 76:217–221PubMedCrossRef
24.
go back to reference Braak H, de Vos RA, Bohl J, Del Tredici K (2006) Gastric alpha-synuclein immunoreactive inclusions in Meissner’s and Auerbach’s plexuses in cases staged for Parkinson’s disease-related brain pathology. Neurosci Lett 396:67–72PubMedCrossRef Braak H, de Vos RA, Bohl J, Del Tredici K (2006) Gastric alpha-synuclein immunoreactive inclusions in Meissner’s and Auerbach’s plexuses in cases staged for Parkinson’s disease-related brain pathology. Neurosci Lett 396:67–72PubMedCrossRef
25.
go back to reference Kupsky WJ, Grimes MM, Sweeting J, Bertsch R, Cote LJ (1987) Parkinson’s disease and megacolon: concentric hyaline inclusions (Lewy bodies) in enteric ganglion cells. Neurology 37:1253–1255PubMed Kupsky WJ, Grimes MM, Sweeting J, Bertsch R, Cote LJ (1987) Parkinson’s disease and megacolon: concentric hyaline inclusions (Lewy bodies) in enteric ganglion cells. Neurology 37:1253–1255PubMed
26.
27.
go back to reference Caplan LH, Jacobson HG, Rubinstein BM, Rotman MZ (1965) Megacolon and volvulus in Parkinson’s disease. Radiology 85:73–78PubMed Caplan LH, Jacobson HG, Rubinstein BM, Rotman MZ (1965) Megacolon and volvulus in Parkinson’s disease. Radiology 85:73–78PubMed
28.
go back to reference Edwards LL, Pfeiffer RF, Quigley EMM, Hofman R, Balluff M (1991) Gastrointestinal symptoms in Parkinson’s disease. Mov Disord 6:151–156PubMedCrossRef Edwards LL, Pfeiffer RF, Quigley EMM, Hofman R, Balluff M (1991) Gastrointestinal symptoms in Parkinson’s disease. Mov Disord 6:151–156PubMedCrossRef
29.
go back to reference Klaue R (1940) Parkinsonsche Krankheit (Paralysis agitans) und postencephalitischer Parkinsonismus. Archiv für Psychiatrie 111:251–321CrossRef Klaue R (1940) Parkinsonsche Krankheit (Paralysis agitans) und postencephalitischer Parkinsonismus. Archiv für Psychiatrie 111:251–321CrossRef
30.
go back to reference Kuroiwa Y, Shimada Y, Toyokura Y (1983) Postural hypotension and low R-R interval variability in parkinsonism, spino-cerebellar degeneration, and Shy-Drager syndrome. Neurology 33:463–467PubMed Kuroiwa Y, Shimada Y, Toyokura Y (1983) Postural hypotension and low R-R interval variability in parkinsonism, spino-cerebellar degeneration, and Shy-Drager syndrome. Neurology 33:463–467PubMed
31.
go back to reference Parkinson J (1817) An essay on the shaking palsy. Sherwood, Neely, and Jones, London, pp 1–66 Parkinson J (1817) An essay on the shaking palsy. Sherwood, Neely, and Jones, London, pp 1–66
32.
go back to reference Turkka JT, Juujärvi KK, Lapinlampi TO, Myllylä VV (1986) Serum noradrenaline response to standing up in patients with Parkinson’s disease. Eur Neurol 25:355–361PubMedCrossRef Turkka JT, Juujärvi KK, Lapinlampi TO, Myllylä VV (1986) Serum noradrenaline response to standing up in patients with Parkinson’s disease. Eur Neurol 25:355–361PubMedCrossRef
33.
go back to reference Korczyn AD (1990) Autonomic nervous system disturbances in Parkinson’s disease. Adv Neurol 53:463–468PubMed Korczyn AD (1990) Autonomic nervous system disturbances in Parkinson’s disease. Adv Neurol 53:463–468PubMed
34.
go back to reference Sakakibara R, Shinotoh H, Uchiyama T, Sakuma M, Kashiwado M, Yoshiyama M, Hattori T (2001) Questionnaire-based assessment of pelvic organ dysfunction in Parkinson’s disease. Auton Neurosci 92:76–85PubMedCrossRef Sakakibara R, Shinotoh H, Uchiyama T, Sakuma M, Kashiwado M, Yoshiyama M, Hattori T (2001) Questionnaire-based assessment of pelvic organ dysfunction in Parkinson’s disease. Auton Neurosci 92:76–85PubMedCrossRef
35.
go back to reference Abbott RD, Petrovitch H, White LR, Masaki KH, Tanner CM, Curb JD, Grandinetti A, Blanchette PL, Popper JS, Ross GW (2001) Frequency of bowel movements and the risk of Parkinson’s disease. Neurology 57:456–462PubMed Abbott RD, Petrovitch H, White LR, Masaki KH, Tanner CM, Curb JD, Grandinetti A, Blanchette PL, Popper JS, Ross GW (2001) Frequency of bowel movements and the risk of Parkinson’s disease. Neurology 57:456–462PubMed
36.
go back to reference Wolters ECh, Braak H (2006) Parkinson’s disease: premotor clinico-pathological correlations. J Neural Transm Suppl 70:309–319PubMedCrossRef Wolters ECh, Braak H (2006) Parkinson’s disease: premotor clinico-pathological correlations. J Neural Transm Suppl 70:309–319PubMedCrossRef
37.
go back to reference Cersosimo MG, Benarroch EE (2008) Neural control of the gastrointestinal system: implications for Parkinson’s disease. Mov Disord 23:1065–1075PubMedCrossRef Cersosimo MG, Benarroch EE (2008) Neural control of the gastrointestinal system: implications for Parkinson’s disease. Mov Disord 23:1065–1075PubMedCrossRef
38.
go back to reference Edwards LL, Quigley EM, Pfeiffer RF (1992) Gastrointestinal dysfunction in Parkinson’s disease: frequency and pathophysiology. Neurology 42:726–732PubMed Edwards LL, Quigley EM, Pfeiffer RF (1992) Gastrointestinal dysfunction in Parkinson’s disease: frequency and pathophysiology. Neurology 42:726–732PubMed
39.
go back to reference Jost WH (1997) Gastrointestinal motility problems in patients with Parkinson’s disease. Effects of antiparkinsonian treatment and guidelines for management. Drugs Aging 10:249–258PubMedCrossRef Jost WH (1997) Gastrointestinal motility problems in patients with Parkinson’s disease. Effects of antiparkinsonian treatment and guidelines for management. Drugs Aging 10:249–258PubMedCrossRef
40.
go back to reference Lanfranchi GA, Marzio L, Cortini C (1977) Effect of dopamine in gastric motility in man: evidence for specific receptors. In: Duthie HL (ed) Gastrointestinal motility in health and disease. MTP Publishers, Lancaster, pp 161–172 Lanfranchi GA, Marzio L, Cortini C (1977) Effect of dopamine in gastric motility in man: evidence for specific receptors. In: Duthie HL (ed) Gastrointestinal motility in health and disease. MTP Publishers, Lancaster, pp 161–172
41.
go back to reference Urbain JL, Charkes ND (1995) Recent advances in gastric emptying scintigraphy. Semin Nucl Med 25:318–325PubMedCrossRef Urbain JL, Charkes ND (1995) Recent advances in gastric emptying scintigraphy. Semin Nucl Med 25:318–325PubMedCrossRef
Metadata
Title
Is there a delayed gastric emptying of patients with early-stage, untreated Parkinson’s disease? An analysis using the 13C-acetate breath test
Authors
Yuji Tanaka
Tomohiro Kato
Hiroshi Nishida
Megumi Yamada
Akihiro Koumura
Takeo Sakurai
Yuichi Hayashi
Akio Kimura
Isao Hozumi
Hiroshi Araki
Masahiko Murase
Masahito Nagaki
Hisataka Moriwaki
Takashi Inuzuka
Publication date
01-03-2011
Publisher
Springer-Verlag
Published in
Journal of Neurology / Issue 3/2011
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-010-5769-z

Other articles of this Issue 3/2011

Journal of Neurology 3/2011 Go to the issue